Institute for Clinical Evaluative Sciences (ICES)

Home
Canada
Toronto, ON
Institute for Clinical Evaluative Sciences (ICES)

Our mission is translating data into trusted evidence that makes policy and health care better.

ICES (formerly Institute for Clinical Evaluative Sciences) is a not-for-profit research institute encompassing a community of research, data and clinical experts, and a secure and accessible array of Ontario's health-related data.

06/05/2026

What caught your attention in health research this week?

In this week's ICYMI:
🔹 Burn survivor care and primary care utilization
🔹 Self-rated health as a predictor of cardiovascular disease
🔹 Robotic knee replacement and surgical outcomes
🔹 Canada's rare disease strategy
🔹 New pharmaceutical data insights from CIHI
🔹 A public discussion on contraception and reproductive health
🔹 And much more

Catch up on the latest research, data, events, and health system conversations shaping healthcare in Canada.

Read the edition: https://www.linkedin.com/pulse/may-29-june-5-2026-ices-research-institute-smaoe

06/03/2026

Have you listened to the latest episode of In Our VoICES yet?

What does the latest data actually tell us about ADHD and pregnancy — and how can those conversations stay supportive instead of stigmatizing?

Dr. Jonathan Zipursky joins host Misty Pratt to discuss a new study on ADHD and pregnancy, including what the findings mean for people who are pregnant, planning a pregnancy, or caring for a newborn.

One key takeaway: data should inform supportive care — not stigma.

The conversation also explores why more people are being diagnosed with ADHD during their reproductive years, how Ontario health data helps answer important questions, and what future research may reveal about ADHD medications during pregnancy and postpartum.

We’re also trying out a new short-form episode format and would love your feedback! Let us know what you think by reaching out to [email protected].

🎧 Catch up on the episode wherever you get your podcasts: https://www.ices.on.ca/podcast/what-the-data-really-says-about-adhd-in-pregnancy-with-dr-jonathan-zipursky/

05/28/2026

📣REMINDER: Join us today at noon for the ECS Rounds exploring the development and validation of a new AI-based tool designed to identify premature newborns at risk at the time of birth through a collaboration between Stanford Medicine and .

🔗Join Zoom Meeting:
https://us06web.zoom.us/j/84122810121?pwd=WDRzUE8yR1dhdlFHRkI0dVFIUFpkQT09

Meeting ID: 841 2281 0121
Passcode: 1234

05/27/2026

New episode alert 🎙️

What do we actually know about ADHD and pregnancy — and how can we talk about risk without shame or fear?

In this episode of In Our VoICES, host Misty Pratt speaks with Dr. Jonathan Zipursky about new research examining ADHD, pregnancy, and newborn health outcomes using Ontario health data.

We’re also trying out a new short-form episode format and would love your feedback! Let us know what you think by reaching out to [email protected].

🎧 Listen now to hear a thoughtful, evidence-based conversation grounded in compassion: https://www.ices.on.ca/podcast/what-the-data-really-says-about-adhd-in-pregnancy-with-dr-jonathan-zipursky/

05/26/2026

Join us for the next ECS Rounds exploring the development and validation of a new AI-based tool designed to identify premature newborns at risk at the time of birth through a collaboration between Stanford Medicine and .

📅 Wednesday, May 28
🕛 12:00–1:00 PM

🔗Join Zoom Meeting:
https://us06web.zoom.us/j/84122810121?pwd=WDRzUE8yR1dhdlFHRkI0dVFIUFpkQT09

Meeting ID: 841 2281 0121
Passcode: 1234

05/25/2026

In recognition of Brain Tumour Awareness Month, is highlighting new research on glioblastoma care in Ontario over a 25-year period (1994–2018).

The study found that more aggressive treatment approaches have become increasingly common, with 2-year survival rates improving from 10% to 18% over the study period. Researchers also observed a reduction in time spent in hospital — both in the total number of days and as a proportion of survival time — despite patients receiving more intensive care.

Although the study did not examine how patients spent this additional time, the findings may point to patients having more quality time outside of hospital. Overall, the results demonstrate continued progress in glioblastoma care and may help inform future treatment decisions for patients, clinicians and health systems alike.

🔗Read the study: https://www.ices.on.ca/publications/journal-articles/a-population-based-cohort-study-of-glioblastoma-who-grade-4-gliomas-in-ontario/

05/22/2026

What are we learning from recent research on treatment retention, maternal health, and continuity of care?

ICYMI: This week’s studies explore faster adjustment of opioid agonist therapy in the context of fentanyl, risks in pregnancy among people with chronic inflammatory conditions, and how continuity in primary care can shape end-of-life outcomes.

Plus upcoming events on health data access, research data management, and Canada’s digital health community, along with recent ICES coverage on opioid harms, infectious disease preparedness, and gaps in preventive screening!

🔗Read the edition: https://www.linkedin.com/pulse/may-15-22-2026-ices-research-institute-1ggre

05/21/2026

CAHSPR 2026 is almost here (Ottawa, May 26–28), and is pleased to be there as a bronze sponsor, showcasing new data on how care delivery is changing across the health system.

Our scientists will be sharing findings that speak to how services are being used and how system design can influence patient outcomes.

Aaron Jones will present a five-year population-based study exploring whether the rise in virtual care is linked to recent declines in family physician home visits, including a notable shift where many physicians have reduced or stopped providing home visits altogether.

David Savage will highlight evidence on the role of prevention and primary care in reducing hospital admissions among emergency department patients, underscoring how continuity of care before and after ED visits can help prevent avoidable hospitalizations.

Alyson Mahar will present on the availability of national gastric cancer staging data for cancer health services research, emphasizing how population-stage data is essential for advancing research and improving outcomes for rare and fatal malignancies like stomach cancer.

We encourage attendees to visit the ICES booth during the conference. Come by to learn more about our work, connect with the team, and join the conversation on improving health system performance.

05/19/2026

We’re proud to see our staff representing ICES at CAHSPR 2026 in Ottawa (May 26–28), where we are also a bronze sponsor of this year’s conference.

From examining regional variation in dementia care across Ontario, to understanding how geography shapes access to breast cancer treatment, to exploring severity and care pathways in withdrawal management services, to highlighting how outpatient electroconvulsive therapy after psychiatric hospitalization may reduce psychiatric readmission risk, our team is contributing important evidence to support more equitable, high-quality health system planning.

Join us at the booth during the conference—we’d love to connect with attendees, share our work, and hear your perspectives. Be sure to drop by and say hello!

05/15/2026

ICYMI: This week’s research and events roundup highlights new evidence shaping health policy, patient care, and equitable decision-making across Canada.

📌 New studies explored:
• Dementia, frailty, and end-of-life hospital transfers among long-term care residents
• A race-free kidney survival prediction model for dialysis and transplant patients
• Opioid use during pregnancy among individuals with disabilities

📅 Plus, upcoming opportunities from HDRN Canada, OSSU, and UBC focused on data access, patient-oriented research, and digital storytelling.

📰 In the news: expert perspectives on youth self-harm, endometriosis and birth-defect risk, and lessons from a cruise ship hantavirus outbreak.

Read more in this edition of the ICYMI newsletter ➡️https://www.linkedin.com/pulse/may-8-15-2026-ices-research-institute-gm5ke

Address

2075 Bayview Avenue Suite V106
Toronto, ON
M4N3M5

Telephone

+16474065996

Website

http://www.ices.on.ca/

Alerts

Be the first to know and let us send you an email when Institute for Clinical Evaluative Sciences (ICES) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your organization to be the top-listed Government Service in Toronto?